NYSE · Medical - Devices

Globus Medical, Inc. (GMED) Stock

$76.71 -2.70% NYSE: GMED Healthcare

Valuation

MetricValue
Price$76.71
Market Cap$10.30B
P/E Ratio19.04
P/B Ratio2.15
P/S Ratio3.24
EPS (TTM)$3.92
52-Week High$101.40
52-Week Low$56.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE11.59%
ROA9.76%
ROCE13.03%
Gross Margin16.33%
Operating Margin16.33%
Net Margin17.03%
Debt/Equity0.02
Current Ratio4.27

Annual Financials (USD)

Metric20212022202320242025
Revenue$958.0M$1.0B$1.6B$2.5B$2.9B
Operating Profit$172.0M$228.0M$133.0M$166.0M$480.0M
Net Profit$149.0M$190.0M$123.0M$103.0M$538.0M
EPS$1.44$1.85$1.07$0.75$3.92
Op Margin17.9%22.3%8.5%6.6%16.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0B$2.1B$5.1B$5.3B$5.3B
Total Liabilities$216.0M$230.0M$1.1B$1.1B$730.0M
Cash$193.0M$150.0M$467.0M$784.0M$526.0M
Borrowings$0$6.0M$520.0M$537.0M$119.0M

Latest News

ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? Zacks · Jul 10, 2026 Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now? Zacks · Jul 10, 2026 Should You Continue to Hold OMCL Stock in Your Portfolio Now? Zacks · Jul 9, 2026 GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics Zacks · Jul 9, 2026 Here's Why You Should Hold Avantor Stock in Your Portfolio for Now Zacks · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$276.0M$178.0M$243.0M$521.0M$753.0M
Investing Cash Flow$-433.0M$-184.0M$225.0M$-291.0M$-520.0M
Financing Cash Flow$54.0M$-110.0M$-232.0M$-28.0M$-679.0M
Net Cash Flow$-46.0M$-43.0M$317.0M$317.0M$-258.0M
Free Cash Flow$219.0M$104.0M$165.0M$405.0M$589.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.37
EV / EBITDA11.18
FCF Yield7.36%
Quick Ratio2.93
Interest Coverage—
Return 1Y25.23%
Return 3Y40.80%
Return 5Y-2.33%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATECAlphatec Holdings, Inc. $10.46 -4.30% -15.18 $1.62B 0.00%
BVSBioventus Inc. $13.30 -3.69% 16.85 $908.46M 0.00%
KIDSOrthoPediatrics Corp. $21.95 -2.75% -13.19 $573.11M 0.00%
OFIXOrthofix Medical Inc. $9.38 -2.19% -5.92 $379.16M 0.00%
SIBNSI-BONE, Inc. $19.68 -1.16% -53.21 $882.03M 0.00%

About Globus Medical, Inc.

Globus Medical, Inc. is led by CEO Keith W. Pfeil, employs 6,000 people, headquartered in Audubon, US, publicly traded since 2012.

Globus Medical, Inc. (GMED) stock trades at $76.71 with a market capitalization of $10.30B. The stock is valued at a price-to-earnings (P/E) ratio of 19.04, price-to-book of 2.15, price-to-sales of 3.24. Over the past 52 weeks the stock has ranged between $56.50 and $101.40, and currently trades 24.3% below its 52-week high.

On profitability, Globus Medical, Inc. generates a return on equity (ROE) of 11.59%, return on capital employed of 13.03%, an operating margin of 16.33%, a net profit margin of 17.03%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1257.03 +0.43% JNJ Johnson & Johnson $255.56 +0.90% ABBV AbbVie Inc. $285.42 +0.71% UNH UnitedHealth Group Incorporated Common Stock (DE) $401.43 -1.29% MRK Merck & Company, Inc. Common Stock (new) $145.97 +0.53% NVS Novartis AG $150.62 +0.16% AZN AstraZeneca PLC $165.41 -0.76% TMO Thermo Fisher Scientific Inc $690.00 -0.93% AMGN Amgen Inc. $432.49 -0.35% GILD Gilead Sciences, Inc. $156.19 -0.75% ABT Abbott Laboratories $104.88 +0.19% NVO Novo Nordisk A/S $38.83 -0.99%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.